Remove 2021 Remove Medicaid Remove Prescription Drug Pricing
article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges. US Food and Drug Administration Approval of High-risk Cardiovascular Devices for Use in Children and Adolescents, 1977-2021. Reforming Patient Cost Sharing for Cancer Medications in Medicare Part D. JAMA Oncol. 2022 Aug 4.

article thumbnail

Magnolia Regional used price transparency IT to get more CHF patients to fill their prescriptions

Healthcare It News

"Next, we used MedHx to gather complete patient medication history so we could track whether patients in the study had filled their prescriptions," he added. From July 2020 to September 2021, Magnolia Regional studied medication adherence and prescription fill rates for 417 patients with CHF. ADVICE FOR OTHERS.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Comments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 2023

Health Law Advisor

However, CMS’s release of the Initial Rebate Guidances represents the agency’s first significant opportunity to submit substantive and specific input from the broader stakeholder community with regard to one of the most significant components of the prescription drug pricing changes of the IRA. 7, 2021). 7] 42 U.S.C.

article thumbnail

What’s Expected to Drive Up Health Plan Costs in 2025: GLP-1s, Behavioral Health, and Inflationary Pressures for Hospitals and Doctors – PwC’s Behind the Numbers 2025

Jane Sarashon

This graph diagrams utilization, unit cost, and cost as a percent of overall medical cost trend: note that by the middle of 2023, GLP-1 drug costs for Group health plan members comprised 13.6% in 2021 to 7.3 in 2021 rising to $23.16 of a major pharmacy benefit management (PBM) company, shown in the third bar.

Doctors 59
article thumbnail

New York Enacts Landmark Legislation Regulating PBMs

Health Care Law Brief

On December 31, 2021, New York Governor Kathy Hochul signed landmark legislation to increase the transparency of prescription drug pricing and to establish requirements on pharmacy middlemen. Disclosure requirements.

article thumbnail

Health Provider News – February 18, 2022

Hall Render

Kaiser sees net income top $8B in 2021, operating income fall sharply. Colorado mental health professionals incensed after Medicaid forum that was intended to clear the air. Florida health system settles improper Medicaid payment allegations for $5.5M. Medicaid Managed-Care Proposal Goes to Mississippi Senate.

article thumbnail

Hall Render’s Health Provider News – February 25, 2022

Hall Render

Why some Medicaid providers in Colorado aren’t getting paid. Whitmer signs bills designed to lower prescription drug prices in Michigan. Missouri Takes Months to Process Medicaid Applications — Longer Than Law Allows. Cerner’s 2021: Revenue up 4%, net earnings down 29%. McLaren is moving east.